Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
+44 (0) 203 086 8600 Call us on

Angola Pharmaceuticals and Healthcare Report Q3 2012

824.56

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

£824.56

Change Currency

GBP EURO USD

Market

Healthcare and Medical

Report Type

Market Research

Country

Angola

Published

22 May 2012

Number of Pages

43

Report Delivery

Download

Delivery Lead Time

Immediate

Publisher

Business Monitor International

File Format

PDF

Healthcare may not have been a major concern for Angolas government – which has prioritised economic development over social development during the years since the civil war ended in 2002 – but with a general election scheduled for September 2012 (an exact date had not been set at the time of writing), BMI expects health and education will receive additional investment in 2012 and 2013 to win votes. For international investors, Angolas pharmaceuticals and healthcare market holds limited appeal, with low spending, an abundance of counterfeit drugs, considerable operational risks due to little intellectual property(IP) protection or regulation and a burden of communicable and non-communicable diseases its key characteristics.

Headline Expenditure Forecasts

- Pharmaceuticals: AOA26.78bn (US$286mn) in 2011 to AOA30.02bn (US$320mn) in 2012; +12.1% in local currency and +12.0% in US dollar terms.

- Healthcare: AOA480.04bn (US$5.12bn) in 2011 to AOA583.07bn (US$6.22bn) in 2012; +21.5% in local currency and +21.3% in US dollar terms.

- Medical Devices: AOA19.06bn (US$203mn) in 2011 to AOA22.43mn (US$239mn) in 2012; +17.7% in local currency and +17.6% in US dollar terms.

Risk/Reward Rating

Angola scores 33.3 out of 100 in the Q312 Pharmaceutical and Healthcare Risk/Reward Ratings (RRRs) and ranks 27th out of 30 in BMIs Middle East and Africa (MEA) regional ratings. This is below the regional average of 44.5. Angola has below-average scores in all categories, with the exception of country rewards, for which it has a score of 63 out of 100.



Key Trends

And Developments

- Angola and Vietnam will consider the creation of a bilateral cooperation agreement regarding the production of essential medicines, the purchasing of drugs and training drug production staff, following Vice President Fernando da Peidades five-day visit to Vietnam in February.

- Esso Exploration Angola and the Exxon Mobile Foundation have provided US$1.5mn in funding for two new maternity hospitals in Cacuaco and Kilamba Kiaxi in Luanda.

- In April 2012, Dr Antonia Muangala told state news agency ANGOP that the government plans to open a nuclear medicine centre for the diagnosis and treatment of various diseases.

BMI Economic View

Angolas economy is booming, with BMI forecasting double-digit GDP growth of 12.8% in 2012 and a similarly high rate of 10.3% in 2013. Oil continues to be the backbone of Angolas economic success and its guaranteed revenue will help President José Eduardo dos Santos fund pre- and post-election spending. In order to win voters favour, we expect increased investment in education and healthcare over the next two years.

BMI Political View

There is likely to be very little change following the general election – only the second since the civil war ended in 2002 – with the governing Movimento Popular de Libertação de Angola (MPLA) certain to achieve a comfortable victory. The transparency of elections remains questionable following the reappointment of Susana Ingles as the head of the National Electoral Commission – the same person who oversaw 2008s controversial election

The price of this market report covers 4 quarterly reports on this sector. This quarterly report will be downloadable instantly as a PDF document, with the 3 remaining reports delivered at regular intervals throughout the year.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

£824.56

Change Currency

GBP EURO USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Healthcare and Medical Company Profiles

Find latest Healthcare and Medical Company Profiles with up to date financial, strategic, operational, SWOT analysis and product information for the leading healthcare and medical companies.

Competitor Tracking

Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Accessibility
Close

Contrast settings

Text size settings